Inhibiting TREM-1 signaling has protective effects in a variety of inflammatory conditions, including inflammatory arthritis [72,120,121], inflammatory bowel disease [90], pancreatitis [122], sepsis [5,19,108], myocardial inflammation [54], hemorrhagic shock, and acute ischemia–reperfusion [123]. Here, TREM1 is linked to inflammatory bowel disease.